These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 21593861)
1. Cardiovascular biology. Thomas C Nature; 2011 May; 473(7347):297. PubMed ID: 21593861 [No Abstract] [Full Text] [Related]
2. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Wong TY Am J Ophthalmol; 2009 Sep; 148(3):327-9. PubMed ID: 19703607 [No Abstract] [Full Text] [Related]
3. [Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care]. Khalaim AV; Stoliarenko GE Vestn Oftalmol; 2007; 123(5):54-6, preceding 56. PubMed ID: 18078062 [No Abstract] [Full Text] [Related]
4. Vascular actions of insulin with implications for endothelial dysfunction. Potenza MA; Addabbo F; Montagnani M Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E568-77. PubMed ID: 19491294 [TBL] [Abstract][Full Text] [Related]
5. Retinal anti-angiogenesis by a new route. Bicknell R Nat Biotechnol; 2008 May; 26(5):528-9. PubMed ID: 18464784 [No Abstract] [Full Text] [Related]
13. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Griffioen AW; Molema G Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101 [TBL] [Abstract][Full Text] [Related]
14. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes. Ceriello A Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S15-9. PubMed ID: 20489415 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Partanen TA; Paavonen K Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156 [TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF therapy: a new approach to colorectal cancer therapy. Carrato A; Gallego-Plazas J; Guillen-Ponce C Expert Rev Anticancer Ther; 2006 Oct; 6(10):1385-96. PubMed ID: 17069524 [TBL] [Abstract][Full Text] [Related]
18. Measures of vascular reactivity: prognostic crystal ball or Pandora's box? Minson CT; Green DJ J Appl Physiol (1985); 2008 Aug; 105(2):398-9. PubMed ID: 18556427 [No Abstract] [Full Text] [Related]
19. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
20. Use of angiogenesis inhibitors in tumour treatment. Fayette J; Soria JC; Armand JP Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]